{"DataElement":{"publicId":"7060637","version":"1","preferredName":"Breast Hormone Receptor Tumor Marker Diagnosis Result Type","preferredDefinition":"The outcome from pathological tests to determine presence of the hormone receptor in the nature of cancer by evaluating a sample of breast tissue.","longName":"BRST_HR_RECP_TM_DX_RST_TP","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2010399","version":"3","preferredName":"Breast Hormone Receptor Tumor Marker Final Diagnosis Result","preferredDefinition":"related to the last outcome from pathologic tests to determine presence and nature of cancer by evaluating breast tissue for ligand binding proteins (hormones) present in or produced by tumor.","longName":"BR_HRMR_TMM_F_DX_RES","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2491438","version":"1","preferredName":"Breast Hormone Receptor Tumor Marker","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:Ligand binding proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell.  The hormone receptor can be cytoplasmic/nuclear, or associated with the cell membrane in the case of receptors whose ligands cannot penetrate the membrane.:A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker.","longName":"C12971:C28154:C17220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hormone Receptor","conceptCode":"C28154","definition":"Ligand binding proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell.  The hormone receptor can be cytoplasmic/nuclear, or associated with the cell membrane in the case of receptors whose ligands cannot penetrate the membrane.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17243E72-E74D-2B65-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-26","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-26","modifiedBy":"ONEDATA","dateModified":"2006-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2491448","version":"1","preferredName":"Final Diagnosis Result","preferredDefinition":"Conclusive in a process or progression.:The process of identifying a disease by the signs and symptoms.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C25508:C15220:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Final","conceptCode":"C25508","definition":"Conclusive in a process or progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"172541B0-2811-4602-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-26","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-26","modifiedBy":"ONEDATA","dateModified":"2006-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17233FB0-2FAC-0625-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-26","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7060635","version":"1","preferredName":"Tumor Marker Pathology Diagnosis Result Type","preferredDefinition":"the outcome reported from pathologic tests to determine presence and nature of cancer by evaluating a sample of tissue for substances present in or produced by tumor.","longName":"7060635v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"70","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Estrogen Receptor Positive And Progesterone Receptor Positive","valueDescription":"Estrogen Receptor Positive And Progesterone Receptor Positive","ValueMeaning":{"publicId":"7060640","version":"1","preferredName":"Estrogen Receptor Positive And Progesterone Receptor Positive","longName":"7060640","preferredDefinition":"Describes cells that have a receptor protein that binds the hormone estrogen. Cancer cells that are estrogen receptor positive may need estrogen to grow, and may stop growing or die when treated with substances that block the binding and actions of estrogen.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Describes cells that have a protein to which the hormone progesterone will bind. Cancer cells that are progesterone receptor positive need progesterone to grow and will usually stop growing when treated with hormones that block progesterone from binding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Positive","conceptCode":"C15492","definition":"An indication that estrogen receptor alpha expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progesterone Receptor Positive","conceptCode":"C15496","definition":"An indication that progesterone receptor (PRG; PR) expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97B6560E-D922-2A99-E053-F662850AA2B4","latestVersionIndicator":"Yes","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"ONEDATA","dateModified":"2019-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97B6560E-D93D-2A99-E053-F662850AA2B4","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"ONEDATA","dateModified":"2019-11-19","deletedIndicator":"No"},{"value":"Progesterone Receptor Negative","valueDescription":"Progesterone Receptor Negative","ValueMeaning":{"publicId":"5497688","version":"1","preferredName":"Progesterone Receptor Negative","longName":"5497688","preferredDefinition":"Describes cells that do not have a protein to which the hormone progesterone will bind. Cancer cells that are progesterone receptor negative do not need progesterone to grow, and usually do not stop growing when treated with hormones that block progesterone from binding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progesterone Receptor Negative","conceptCode":"C15497","definition":"An indication that progesterone receptor (PRG; PR) expression has not been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DF8E839-8415-2309-E053-F662850A7FBB","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-03","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97B5F174-F41F-29C8-E053-F662850AA828","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"ONEDATA","dateModified":"2019-11-19","deletedIndicator":"No"},{"value":"Estrogen Receptor Negative and Progesterone Receptor Negative","valueDescription":"Estrogen Receptor Negative And Progesterone Receptor Negative","ValueMeaning":{"publicId":"7060636","version":"1","preferredName":"Estrogen Receptor Negative And Progesterone Receptor Negative","longName":"7060636","preferredDefinition":"Describes cells that do not have a protein to which the hormone estrogen will bind. Cancer cells that are estrogen receptor negative do not need estrogen to grow, and usually do not stop growing when treated with hormones that block estrogen from binding.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Describes cells that do not have a protein to which the hormone progesterone will bind. Cancer cells that are progesterone receptor negative do not need progesterone to grow, and usually do not stop growing when treated with hormones that block progesterone from binding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Negative","conceptCode":"C15493","definition":"The absence of detectable estrogen receptor alpha in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progesterone Receptor Negative","conceptCode":"C15497","definition":"An indication that progesterone receptor (PRG; PR) expression has not been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97B5F174-F42E-29C8-E053-F662850AA828","latestVersionIndicator":"Yes","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"ONEDATA","dateModified":"2019-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97B5F174-F449-29C8-E053-F662850AA828","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"ONEDATA","dateModified":"2019-11-19","deletedIndicator":"No"},{"value":"Estrogen Receptor Negative","valueDescription":"Estrogen Receptor Negative","ValueMeaning":{"publicId":"5497686","version":"1","preferredName":"Estrogen Receptor Negative","longName":"5497686","preferredDefinition":"Describes cells that do not have a protein to which the hormone estrogen will bind. Cancer cells that are estrogen receptor negative do not need estrogen to grow, and usually do not stop growing when treated with hormones that block estrogen from binding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Negative","conceptCode":"C15493","definition":"The absence of detectable estrogen receptor alpha in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DF8E839-83EF-2309-E053-F662850A7FBB","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-03","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97B5F174-F453-29C8-E053-F662850AA828","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"ONEDATA","dateModified":"2019-11-19","deletedIndicator":"No"},{"value":"Progesterone Receptor Positive","valueDescription":"Progesterone Receptor Positive","ValueMeaning":{"publicId":"4411285","version":"1","preferredName":"Progesterone Receptor Positive","longName":"4411285","preferredDefinition":"Describes cells that have a protein to which the hormone progesterone will bind. Cancer cells that are progesterone receptor positive need progesterone to grow and will usually stop growing when treated with hormones that block progesterone from binding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progesterone Receptor Positive","conceptCode":"C15496","definition":"An indication that progesterone receptor (PRG; PR) expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6E85-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97B5F174-F45F-29C8-E053-F662850AA828","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"ONEDATA","dateModified":"2019-11-19","deletedIndicator":"No"},{"value":"Estrogen Receptor Positive","valueDescription":"Estrogen Receptor Positive","ValueMeaning":{"publicId":"4264820","version":"1","preferredName":"Estrogen Receptor Positive","longName":"4264820","preferredDefinition":"Describes cells that have a receptor protein that binds the hormone estrogen. Cancer cells that are estrogen receptor positive may need estrogen to grow, and may stop growing or die when treated with substances that block the binding and actions of estrogen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Positive","conceptCode":"C15492","definition":"An indication that estrogen receptor alpha expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FD23-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97B5F174-F46B-29C8-E053-F662850AA828","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"ONEDATA","dateModified":"2019-11-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"97B5F174-F405-29C8-E053-F662850AA828","latestVersionIndicator":"Yes","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"SOKKERL","dateModified":"2020-02-18","changeDescription":"11/19/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Hormone Receptor Status","type":"Preferred Question Text","description":"Hormone Receptor Status","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"97B60688-952E-3965-E053-F662850AB196","latestVersionIndicator":"Yes","beginDate":"2019-11-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-19","modifiedBy":"SOKKERL","dateModified":"2020-02-18","changeDescription":"11/19/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}